生物降解的聚基超分支纳米载体与N-乙葡萄糖胺修饰,通过GLUT有效地向癌细胞输送药物
Aazam Shaikh1,2, Rajesh Salve1,2, Devyani Sengar1,2
1Nanobioscience Group, Agharkar Research Institute, Pune, India.
Frontiers in bioengineering and biotechnology
|March 17, 2025
概括
工程设计的N-乙葡萄糖胺结合的高分支聚合物显示在癌细胞中增加了多克索鲁比的积累. 这种向的纳米载体传递改善了乳腺癌细胞的杀死,提供了更有选择性的化疗方法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症是导致死亡的主要原因,需要改进治疗策略.
- 目前的癌症疗法,如化疗,由于对健康组织的附带损伤,导致显著的副作用.
- 超分支聚合物为向向癌细胞输送药物提供了潜在的潜力.
研究的目的:
- 为向癌症治疗设计N-乙葡萄糖胺 (NAG) 结合的高分支聚合物.
- 评估这些改造的纳米载体的增强药物输送和有效性.
- 为了比较NAG结合聚合物的向传递和细胞毒性作用与未经修改的版本.
主要方法:
- 使用1H NMR,动态光散射和FTIR光谱学合成和表征N-乙葡萄糖胺结合高分支聚合物 (H40 BoltornTM).
- 对焦显微镜用于评估癌细胞中多克索鲁比的积累.
- 在MDA-MB-231和4T1乳腺癌细胞系上的药物载荷纳米载体的体外评估.
主要成果:
- 与未经修改的聚合物相比,N-乙葡萄糖胺结合增强了多克索鲁比在癌细胞中的积累.
- 经过修改的H40 BoltornTM纳米载体对乳腺癌细胞系表现出优异的细胞毒性作用.
- 通过NAG结合的向输送显著提高了抗癌药物输送的有效性.
结论:
- 与N-乙葡萄糖胺结合的高分支聚合物代表了针对性抗癌药物输送的有希望的平台.
- 这种有针对性的方法增强了乳腺癌细胞的选择性杀死,最大限度地减少对健康组织的损害.
- 工程纳米载体提供了一个更有效和选择性的化疗策略.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


